TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P33
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | -21.87% |
| 2024 | -77.74% |
| 2023 | 8.80% |
| 2022 | -20.66% |
| 2021 | -707.30% |
| 2020 | 47.27% |
| 2019 | 0.00% |